https://old.journalforclinicalstudies.com/fda-greenlights-genentechs-eye-implant-for-macular-degeneration-will-it-be-a-tough-sell/ 2021-11-08T15:37:39+00:00 https://old.journalforclinicalstudies.com/sanofi-and-regenerons-dupixent-aces-another-test-this-time-in-the-debilitating-itch-condition-prurigo-nodularis/ 2021-11-08T15:36:31+00:00 https://old.journalforclinicalstudies.com/pfizers-covid-19-vaccine-is-safe-effective-in-kids-ages-5-to-11-setting-up-possible-fda-nod/ 2021-11-08T15:35:47+00:00 https://old.journalforclinicalstudies.com/johnson-johnson-wins-fda-panel-backing-for-a-second-dose-of-its-covid-shot-but-dont-call-it-a-booster/ 2021-11-08T15:34:55+00:00 https://old.journalforclinicalstudies.com/roche-ushers-early-lung-cancer-into-immunotherapy-era-with-tecentriq-fda-approval-will-doctors-follow/ 2021-11-08T15:34:07+00:00 https://old.journalforclinicalstudies.com/revances-botox-rival-turned-away-by-fda-after-inspectors-flagged-manufacturing-deficiencies/ 2021-11-08T15:32:59+00:00 https://old.journalforclinicalstudies.com/pfizer-moderna-will-rake-in-a-combined-93-billion-next-year-on-covid-19-vaccine-sales/ 2021-11-08T15:32:02+00:00 https://old.journalforclinicalstudies.com/fda-delays-decision-on-modernas-covid-19-vaccine-in-12-17-age-group-because-of-myocarditis-concerns/ 2021-11-08T15:31:04+00:00 https://old.journalforclinicalstudies.com/fda-ready-to-bless-mixing-and-matching-of-covid-19-vaccines-as-boosters/ 2021-11-08T15:29:53+00:00 https://old.journalforclinicalstudies.com/glaxosmithkline-to-leave-landmark-global-hq-after-split-up-as-consumer-health-business-plots-120m-new-home/ 2021-11-08T15:28:41+00:00 https://old.journalforclinicalstudies.com/ipsen-poaches-novartis-vet-scheiffele-to-serve-as-president-of-its-international-specialty-care-team/ 2021-11-08T15:27:21+00:00 https://old.journalforclinicalstudies.com/viatris-to-close-former-novartis-site-in-california-in-january-lay-off-75/ 2021-11-08T15:26:15+00:00 https://old.journalforclinicalstudies.com/supernus-strikes-400m-adamas-buyout-as-its-top-drug-heads-toward-the-patent-cliff/ 2021-11-08T15:25:24+00:00 https://old.journalforclinicalstudies.com/merck-started-its-acceleron-pursuit-at-160-per-share-but-ceo-davis-balked-at-paying-more-than-180/ 2021-11-08T15:24:15+00:00 https://old.journalforclinicalstudies.com/pacira-boosts-non-opioid-pain-portfolio-via-450m-flexion-buy-with-more-cvr-payments-to-come/ 2021-11-08T15:22:51+00:00 https://old.journalforclinicalstudies.com/eyes-itching-from-allergies-oculars-dextenza-wins-fda-approval-as-first-monthly-implant/ 2021-11-08T15:20:29+00:00 https://old.journalforclinicalstudies.com/merck-and-ridgebacks-molnupiravir-will-be-complementary-but-not-a-competitor-to-covid-19-vaccines-analyst/ 2021-11-08T15:19:20+00:00 https://old.journalforclinicalstudies.com/as-revance-nears-a-potential-launch-for-its-botox-rival-abbvie-sues-for-patent-infringement/ 2021-11-08T15:18:06+00:00 https://old.journalforclinicalstudies.com/gileads-kite-enters-leukemia-with-tecartus-fda-approval-overlapping-novartis-car-t-rival-kymriah/ 2021-11-08T15:17:01+00:00 https://old.journalforclinicalstudies.com/racing-rival-pfizer-mercks-vaxneuvance-makes-its-case-for-an-fda-approval-in-children/ 2021-11-08T15:15:39+00:00 https://old.journalforclinicalstudies.com/researchers-retract-preprint-study-that-miscalculated-higher-heart-inflammation-risk-for-moderna-pfizer-covid-vaccines/ 2021-11-08T14:59:04+00:00 https://old.journalforclinicalstudies.com/biohavens-nurtec-with-dual-migraine-approvals-hits-136m-in-quarterly-sales-and-leads-the-pack-in-market-share/ 2021-11-08T14:55:28+00:00 https://old.journalforclinicalstudies.com/glaxosmithkline-relocates-us-operations-in-philadelphia-north-carolina-as-covid-19-cuts-its-office-space-needs/ 2021-11-08T14:53:39+00:00 https://old.journalforclinicalstudies.com/bristol-myers-squibb-previews-new-transformation-corporate-brand-campaign-at-annual-global-patients-event/ 2021-11-08T14:49:28+00:00 https://old.journalforclinicalstudies.com/mercks-reported-11b-acceleron-buy-could-help-it-diversify-beyond-keytruda-but-antitrust-hurdles-loom/ 2021-11-08T14:44:44+00:00 https://old.journalforclinicalstudies.com/amgens-repatha-gains-an-edge-on-rival-praluent-with-fda-approval-to-treat-children-with-rare-cholesterol-condition/ 2021-11-08T14:36:11+00:00 https://old.journalforclinicalstudies.com/hikma-bolsters-injectables-franchise-with-425m-deal-for-custopharm-but-ftc-review-looms/ 2021-11-08T14:29:40+00:00 https://old.journalforclinicalstudies.com/glaxosmithklines-long-acting-hiv-drug-nabs-fda-priority-review-as-a-preventative-option/ 2021-11-08T14:27:27+00:00 https://old.journalforclinicalstudies.com/amid-new-pricing-pressure-lilly-cuts-cost-of-generic-insulin-by-another-40/ 2021-11-08T14:26:13+00:00 https://old.journalforclinicalstudies.com/fdas-marks-takes-over-vaccines-office-as-agency-prepares-to-part-ways-with-2-key-officials/ 2021-11-08T14:24:28+00:00 https://old.journalforclinicalstudies.com/emmes-standardises-on-veeva-development-cloud-to-streamline-product-development/ 2021-11-08T14:21:46+00:00 https://old.journalforclinicalstudies.com/in-newly-diagnosed-stomach-cancer-2-opdivo-yervoy-flops-show-immunotherapy-alone-might-not-be-the-answer/ 2021-11-08T14:19:55+00:00 https://old.journalforclinicalstudies.com/novartis-determined-to-dethrone-pfizer-will-launch-bold-kisqali-ibrance-head-to-head-trial-in-breast-cancer/ 2021-11-08T14:18:41+00:00 https://old.journalforclinicalstudies.com/esmo-bristol-myers-opdivo-yervoy-pfizer-merck-kgaas-bavencio-hit-walls-in-head-and-neck-cancer/ 2021-11-08T14:17:03+00:00 https://old.journalforclinicalstudies.com/former-mylan-executive-pleads-guilty-to-insider-trading-that-netted-him-4-27m/ 2021-11-08T13:50:16+00:00 https://old.journalforclinicalstudies.com/biogen-beefs-up-in-biosimilars-again-with-fda-nod-for-samsung-partnered-lucentis-copycat/ 2021-11-08T13:38:18+00:00 https://old.journalforclinicalstudies.com/pfizer-plans-to-seek-fda-nod-for-covid-19-shot-in-kids-5-to-11-after-positive-data/ 2021-11-08T13:36:24+00:00 https://old.journalforclinicalstudies.com/merck-womens-health-spinoff-organon-debuts-first-awareness-campaign-taking-on-unplanned-pregnancy/ 2021-11-08T13:28:26+00:00 https://old.journalforclinicalstudies.com/amgen-scores-otezla-patent-win-protecting-its-blockbuster-from-sandoz-and-zydus-generics-until-2028/ 2021-11-08T13:26:57+00:00 https://old.journalforclinicalstudies.com/fred-hutch-researchers-tout-iclusigs-potential-to-tame-cytokine-storm-in-covid-but-cant-get-takeda-on-board/ 2021-11-08T13:25:59+00:00 https://old.journalforclinicalstudies.com/amid-covids-latest-surge-regeneron-and-eli-lilly-score-new-antibody-supply-deals-with-the-u-s/ 2021-11-08T13:24:46+00:00 https://old.journalforclinicalstudies.com/citing-less-than-optimal-outcomes-for-roches-evrysdi-biogen-launches-high-dose-spinraza-trial/ 2021-11-08T13:22:44+00:00 https://old.journalforclinicalstudies.com/als-ice-bucket-challenge-advocacy-group-calls-for-speedy-fda-approval-of-amylyx-now-pending-drug/ 2021-11-08T13:21:32+00:00 https://old.journalforclinicalstudies.com/floating-material-found-in-pfizer-covid-19-vaccine-vials-in-japan-but-company-says-its-not-contamination/ 2021-11-08T13:20:21+00:00 https://old.journalforclinicalstudies.com/ceos-of-abbvie-bms-lilly-gsk-and-more-raise-concerns-about-washingtons-intensifying-drug-pricing-push/ 2021-11-08T13:19:14+00:00 https://old.journalforclinicalstudies.com/astrazeneca-strikes-covid-19-vaccine-delivery-deal-with-europe-ending-high-profile-legal-battle/ 2021-11-08T13:17:55+00:00 https://old.journalforclinicalstudies.com/meet-neffy-the-friendly-epinephrine-nasal-spray-from-ars-pharma-awaiting-fda-approval/ 2021-11-08T13:15:42+00:00 https://old.journalforclinicalstudies.com/crippled-by-opioid-crisis-litigation-mallinckrodt-settlement-brings-company-closer-to-reorganisation/ 2021-11-08T13:13:15+00:00 https://old.journalforclinicalstudies.com/after-moderna-contamination-mess-takeda-strikes-deal-with-japan-to-supply-novavax-covid-19-vaccines/ 2021-11-08T13:11:11+00:00 https://old.journalforclinicalstudies.com/bristol-myers-pfizer-score-another-win-in-their-eliquis-patent-defense-protecting-the-blockbuster-until-2028/ 2021-11-08T13:09:43+00:00 https://old.journalforclinicalstudies.com/roches-polivy-to-hit-2-4b-as-doctors-expect-significant-switching-in-newly-diagnosed-lymphoma-analyst/ 2021-11-08T13:07:58+00:00 https://old.journalforclinicalstudies.com/cdc-enlists-comedian-to-embrace-the-awkwardness-of-gynecology-visits-and-encourage-women-to-go/ 2021-11-08T13:06:23+00:00 https://old.journalforclinicalstudies.com/abbvies-imbruvica-patent-win-sets-up-solid-growth-path-after-humiras-decline-analyst/ 2021-11-08T13:04:40+00:00 https://old.journalforclinicalstudies.com/sanofi-refiles-3-2b-translate-bio-buyout-with-ftc-to-allow-more-time-for-review/ 2021-11-08T12:04:56+00:00 https://old.journalforclinicalstudies.com/unlocking-the-opportunities-hidden-in-healthcare-data/ 2021-11-08T12:02:50+00:00 https://old.journalforclinicalstudies.com/key-vaccine-leaders-departing-fda-as-covid-19-booster-questions-linger/ 2021-11-08T12:01:02+00:00 https://old.journalforclinicalstudies.com/fda-approval-of-pfizers-covid-19-vaccine-spurs-american-confidence-harris-poll/ 2021-11-08T11:54:25+00:00 https://old.journalforclinicalstudies.com/three-ways-to-optimize-promotions-and-drive-dynamic-deployment/ 2021-11-08T11:51:30+00:00 https://old.journalforclinicalstudies.com/samsung-plots-205b-investment-massive-hiring-spree-to-ramp-up-cdmo-biosimilars-and-more/ 2021-11-08T11:49:49+00:00 https://old.journalforclinicalstudies.com/novartis-kymriah-flops-in-earlier-lymphoma-use-where-gilead-bristol-myers-car-t-rivals-succeeded/ 2021-11-08T11:47:51+00:00 https://old.journalforclinicalstudies.com/capturing-the-true-value-of-patient-data-by-aligning-stakeholder-incentives/ 2021-11-08T11:43:36+00:00 https://old.journalforclinicalstudies.com/biohaven-points-up-nurtec-dual-migraine-approval-with-growing-stable-of-celebrity-users/ 2021-11-05T16:01:31+00:00 https://old.journalforclinicalstudies.com/manufacturing-issues-force-delay-for-polaritytes-skin-repair-hopeful/ 2021-11-05T15:56:56+00:00 https://old.journalforclinicalstudies.com/organon-shares-jump-as-mercks-new-womens-health-spinoff-posts-strong-start-for-biosims-infertility-drugs/ 2021-11-05T15:38:32+00:00 https://old.journalforclinicalstudies.com/ogilvy-healths-new-pr-practice-chief-talks-pharma-image-and-social-trends/ 2021-11-05T15:37:36+00:00 https://old.journalforclinicalstudies.com/mercks-welireg-scores-fda-nod-in-cancers-spurred-by-rare-disease-and-its-label-is-broader-than-expected/ 2021-11-05T15:36:09+00:00 https://old.journalforclinicalstudies.com/eli-lillys-olympic-run-ends-with-enduring-stories-of-team-usa-athletes-sport-and-health-quests/ 2021-11-05T15:34:24+00:00 https://old.journalforclinicalstudies.com/pfizers-tick-borne-encephalitis-vaccine-ticovac-passes-fda-muster-allowing-travelers-and-the-military-easier-access/ 2021-11-05T15:31:47+00:00 https://old.journalforclinicalstudies.com/after-fibrogens-fda-rejection-in-anemia-akebia-ceo-aims-to-seize-first-in-class-opening-with-vadadustat/ 2021-11-05T15:30:25+00:00 https://old.journalforclinicalstudies.com/viatris-shows-no-signs-of-growing-pains-in-its-trough-year-but-one-analyst-has-longer-term-worries/ 2021-11-05T15:22:35+00:00 https://old.journalforclinicalstudies.com/ginkgo-and-aldevron-tout-mrna-manufacturing-breakthrough-and-the-perks-could-stretch-well-beyond-covid-19-exec-says/ 2021-11-05T15:18:52+00:00 https://old.journalforclinicalstudies.com/roche-snags-coveted-polivy-win-in-newly-diagnosed-lymphoma-but-is-it-enough-to-change-2-decades-of-established-treatment-practices/ 2021-11-05T15:14:06+00:00 https://old.journalforclinicalstudies.com/astrazeneca-daiichi-sankyo-build-enhertus-blockbuster-case-with-breast-cancer-win-against-roches-kadcyla/ 2021-11-05T15:09:54+00:00 https://old.journalforclinicalstudies.com/biontech-eyeing-18b-plus-in-covid-19-vaccine-sales-this-year-poised-to-join-the-ranks-of-the-worlds-top-drugmakers/ 2021-11-05T15:06:59+00:00 https://old.journalforclinicalstudies.com/with-the-pricing-situation-untenable-in-europe-bluebird-will-wind-down-its-operations-in-the-broken-market/ 2021-11-05T15:04:03+00:00 https://old.journalforclinicalstudies.com/virtual-town-halls-provide-timely-support-to-sars-cov-2-test-developers/ 2021-11-05T15:02:31+00:00 https://old.journalforclinicalstudies.com/data-compliance-or-rejection-are-you-ready-for-september-15th/ 2021-11-05T15:00:52+00:00 https://old.journalforclinicalstudies.com/respiratory-disease-diagnosis-and-testing-beyond-covid-19/ 2021-11-05T14:57:05+00:00 https://old.journalforclinicalstudies.com/the-end-of-data-chaos-modernising-data-infrastructure-to-revolutionise-clinical-research/ 2021-11-05T14:55:28+00:00 https://old.journalforclinicalstudies.com/what-a-global-pandemic-taught-us-about-the-pharmaceutical-supply-chain/ 2021-11-05T14:53:47+00:00 https://old.journalforclinicalstudies.com/critical-considerations-for-clinical-trial-safety-reporting-investments/ 2021-11-05T14:51:11+00:00 https://old.journalforclinicalstudies.com/re-evaluating-paediatric-cancer-endpoints/ 2021-11-05T14:48:35+00:00 https://old.journalforclinicalstudies.com/top-5-innovations-in-clinical-trials-that-are-benefiting-the-pharma-industry/ 2021-11-05T14:47:25+00:00 https://old.journalforclinicalstudies.com/expediting-clinical-trials-with-cloud-based-metadata-repository-and-study-automation-technologies/ 2021-11-05T14:45:48+00:00 https://old.journalforclinicalstudies.com/recent-advances-and-future-challenges-using-biomarkers-in-oncology-precision-medicine/ 2021-11-05T14:43:43+00:00 https://old.journalforclinicalstudies.com/mercks-keytruda-scores-first-in-class-nod-in-early-triple-negative-breast-cancer-despite-fdas-prior-reluctance/ 2021-11-05T14:42:06+00:00 https://old.journalforclinicalstudies.com/digital-adherence-modern-solutions-to-an-age-old-problem/ 2021-11-05T14:41:25+00:00 https://old.journalforclinicalstudies.com/digitising-healthcare-the-challenges-and-benefits/ 2021-11-05T14:39:40+00:00 https://old.journalforclinicalstudies.com/covid-19-vaccines-updates-cold-chain-logistics-of-vaccine-distribution/ 2021-11-05T14:38:35+00:00 https://old.journalforclinicalstudies.com/i-dont-like-it-biogens-latest-alzheimers-ad-rouses-fresh-aduhelm-concerns-and-some-defense/ 2021-11-05T14:37:03+00:00 https://old.journalforclinicalstudies.com/new-gsk-shows-strength-amid-investor-pressure-but-shingrix-still-needs-to-regain-its-footing/ 2021-11-05T14:34:22+00:00 https://old.journalforclinicalstudies.com/pfizer-now-expects-covid-vaccine-sales-to-reach-33-5b-this-year-a-whopping-7-5b-bump-from-its-estimate-3-months-ago/ 2021-11-05T14:32:47+00:00 https://old.journalforclinicalstudies.com/lawmakers-press-fda-for-answers-about-its-plans-to-restart-foreign-inspections/ 2021-11-05T14:31:15+00:00 https://old.journalforclinicalstudies.com/pharma-giants-led-by-pfizer-and-jj-play-covid-card-to-fight-global-tax-deal-wsj/ 2021-11-05T14:29:34+00:00 https://old.journalforclinicalstudies.com/emmes-launches-orphan-reach-emmes-rare-disease-center/ 2021-11-04T15:33:21+00:00 https://old.journalforclinicalstudies.com/pfizers-covid-vaccine-for-younger-kids-meets-fda-bar-with-cdc-panel-next-week-being-key-to-wide-rollout/ 2021-11-02T16:30:27+00:00 https://old.journalforclinicalstudies.com/novartis-keeps-the-leukemia-innovation-coming-with-fda-approval-for-gleevec-follow-on-scemblix-as-tasigna-patent-cliff-nears/ 2021-11-02T16:26:39+00:00 https://old.journalforclinicalstudies.com/amid-a-push-to-resolve-opioid-and-talc-claims-johnson-johnson-settles-risperdal-litigation-for-800m/ 2021-11-02T16:22:53+00:00 https://old.journalforclinicalstudies.com/novo-nordisk-casts-queen-latifah-in-tv-themed-awareness-campaign-for-obesity/ 2021-11-02T16:20:31+00:00 https://old.journalforclinicalstudies.com/astrazeneca-resumes-asset-sale-in-270m-copd-deal-with-familiar-buyer-covis/ 2021-11-02T16:16:50+00:00 https://old.journalforclinicalstudies.com/merck-refiles-11-5b-acceleron-deal-with-the-ftc-but-extending-regulators-review-time-only-one-benefit/ 2021-11-02T16:14:03+00:00 https://old.journalforclinicalstudies.com/b-medical-systems-production-area-extension/ 2021-11-02T10:37:44+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2021/10/Luxembourg-factory-launch-scaled.jpg https://old.journalforclinicalstudies.com/flexible-virtual-trials-for-patientcentricity-efficiency-and-better-data/ 2021-10-18T15:09:12+00:00 https://old.journalforclinicalstudies.com/the-central-role-of-interactive-response-technology-in-todays-clinical-trials/ 2021-10-18T15:08:30+00:00 https://old.journalforclinicalstudies.com/the-use-of-psychedelics-in-neuropsychiatry-a-new-era-in-research/ 2021-10-18T15:07:54+00:00 https://old.journalforclinicalstudies.com/from-little-acorns-a-scandinavian-studys-implications-for-paediatric-development/ 2021-10-18T15:07:23+00:00 https://old.journalforclinicalstudies.com/nursing-report-sheet-an-essential-tool-for-the-clinical-research-nurse/ 2021-10-18T15:06:36+00:00 https://old.journalforclinicalstudies.com/clinical-trials-in-medical-devices-life-cycle-risk-management/ 2021-10-18T15:05:47+00:00 https://old.journalforclinicalstudies.com/communicating-with-patients-who-and-how/ 2021-10-18T15:04:21+00:00 https://old.journalforclinicalstudies.com/preparing-at-last-for-idmp-adoption-how-life-sciences-should-ensure-readiness/ 2021-10-18T15:03:40+00:00 https://old.journalforclinicalstudies.com/prevention-is-key-shifting-the-mindset-to-rbqm/ 2021-10-18T15:02:06+00:00 https://old.journalforclinicalstudies.com/a-novel-approach-to-clinical-supply-chain-systems-integration/ 2021-10-18T15:01:29+00:00 https://old.journalforclinicalstudies.com/pandemic-industry-impact-one-year-on/ 2021-10-18T14:59:57+00:00 https://old.journalforclinicalstudies.com/interim-report-shows-fda-meeting-goals-for-efficient-transparent-review-of-biosimilars-applications/ 2021-10-18T14:59:15+00:00 https://old.journalforclinicalstudies.com/assessing-study-design-and-matching-to-systems-based-on-efficiency-and-cost-outline/ 2021-10-18T14:58:26+00:00 https://old.journalforclinicalstudies.com/risk-sharing-for-payer-hta-success/ 2021-07-20T21:05:37+00:00 https://old.journalforclinicalstudies.com/pdx-model-evolution-oncology/ 2021-07-20T21:04:52+00:00 https://old.journalforclinicalstudies.com/new-standards-alzheimers-trial-design/ 2021-07-20T21:04:35+00:00 https://old.journalforclinicalstudies.com/cns-clinical-trials-russia/ 2021-07-20T21:04:18+00:00 https://old.journalforclinicalstudies.com/mobile-technology-reshaping-pharmaceutical-industry/ 2021-07-20T21:04:02+00:00 https://old.journalforclinicalstudies.com/import-investigational-medicinal-products-israel/ 2021-07-20T21:03:43+00:00 https://old.journalforclinicalstudies.com/orphan-drugs-rd-challenges-turkey-middle-east/ 2021-07-20T21:03:26+00:00 https://old.journalforclinicalstudies.com/changing-bleeding-end-points-coronary-interventional-trials/ 2021-07-20T21:02:42+00:00 https://old.journalforclinicalstudies.com/aortic-stiffness-copd-november-2013/ 2021-07-20T21:02:16+00:00 https://old.journalforclinicalstudies.com/cardiovascular-therapeutics-watch-page-november-2013/ 2021-07-20T21:02:00+00:00 https://old.journalforclinicalstudies.com/evolution-trial-master-file-process/ 2021-07-20T21:01:27+00:00 https://old.journalforclinicalstudies.com/under-surveillance-risk-based-monitoring-improves-clinical-trials/ 2021-07-20T21:01:10+00:00 https://old.journalforclinicalstudies.com/patient-recruitment-retention/ 2021-07-20T21:01:00+00:00 https://old.journalforclinicalstudies.com/lebanon-watch-market-report/ 2021-07-20T21:00:13+00:00 https://old.journalforclinicalstudies.com/vendor-management-clinical-operations/ 2021-07-20T20:59:54+00:00 https://old.journalforclinicalstudies.com/recruit-retain-patients-think-like-one/ 2021-07-20T20:59:38+00:00 https://old.journalforclinicalstudies.com/single-shot-dna-vaccines-everlasting-immunity/ 2021-07-20T20:59:22+00:00 https://old.journalforclinicalstudies.com/united-federation-or-mafia/ 2021-07-20T20:58:56+00:00 https://old.journalforclinicalstudies.com/communication-in-life-sciences-openness-cultural-considerations/ 2021-07-20T20:58:33+00:00 https://old.journalforclinicalstudies.com/review-sourcing-approaches-clinical-development/ 2021-07-20T20:58:12+00:00 https://old.journalforclinicalstudies.com/industry-trends-sourcing-clinical-trial-supplies-globally/ 2021-07-20T20:57:50+00:00 https://old.journalforclinicalstudies.com/action-plan-address-demographic-subgroup-data-fda-product-applications/ 2021-07-20T20:56:23+00:00 https://old.journalforclinicalstudies.com/adhd-then-now/ 2021-07-20T20:55:57+00:00 https://old.journalforclinicalstudies.com/dementia-cognitive-impairment-arterial-stiffness-may-2014/ 2021-07-20T20:55:34+00:00 https://old.journalforclinicalstudies.com/logistics-emerging-markets-singapore-investing-future-life-sciences/ 2021-07-20T20:55:17+00:00 https://old.journalforclinicalstudies.com/cardiac-safety-research-consortium-think-tank-for-cv-outcome-studies-february-19-2014/ 2021-07-20T20:55:03+00:00 https://old.journalforclinicalstudies.com/risk-based-monitoring-roundtable-discussion/ 2021-07-20T20:54:45+00:00 https://old.journalforclinicalstudies.com/fda-raises-bar-bioanalytical-method-validation/ 2021-07-20T20:54:28+00:00 https://old.journalforclinicalstudies.com/advantages-challenges-clinical-research-south-africa/ 2021-07-20T20:54:20+00:00 https://old.journalforclinicalstudies.com/improving-treatment-options-in-schizophrenia-considering-the-whole-patient/ 2021-07-20T20:54:08+00:00 https://old.journalforclinicalstudies.com/mauritius-emerging-centre-rd-biotechnology-life-sciences/ 2021-07-20T20:53:24+00:00 https://old.journalforclinicalstudies.com/setting-standard-central-labs-asia-pacific-china/ 2021-07-20T20:53:03+00:00 https://old.journalforclinicalstudies.com/elements-requiring-particular-attention-conducting-clinical-trials-paediatric-population/ 2021-07-20T20:52:46+00:00 https://old.journalforclinicalstudies.com/implications-paediatric-asthma-clinical-trials/ 2021-07-20T20:52:29+00:00 https://old.journalforclinicalstudies.com/paediatric-clinical-trials-central-eastern-europe-here-now/ 2021-07-20T20:52:10+00:00 https://old.journalforclinicalstudies.com/going-native-deciding-optimal-app-approach-smartphone-ecoa/ 2021-07-20T20:51:53+00:00 https://old.journalforclinicalstudies.com/mobile-development-clinical-trials/ 2021-07-20T20:51:35+00:00 https://old.journalforclinicalstudies.com/jcs-interviews-tim-davis-exco-intouch-use-mobile-technology-clinical-trials/ 2021-07-20T20:51:17+00:00 https://old.journalforclinicalstudies.com/fda-suggests-reintroduction-of-bovine-derived-heparin/ 2021-07-20T20:51:01+00:00 https://old.journalforclinicalstudies.com/turkey-at-the-crossroads-of-asia-and-europe/ 2021-07-20T20:50:27+00:00 https://old.journalforclinicalstudies.com/jordans-advancement-into-the-clinical-market-and-its-regulatory-framework/ 2021-07-20T20:48:17+00:00 https://old.journalforclinicalstudies.com/strategic-alignment-essential-for-successful-partnerships/ 2021-07-20T20:48:00+00:00 https://old.journalforclinicalstudies.com/israel-in-translation-conducting-clinical-trials-in-a-multilingual-country/ 2021-07-20T20:47:36+00:00 https://old.journalforclinicalstudies.com/a-road-less-travelled/ 2021-07-20T20:47:21+00:00 https://old.journalforclinicalstudies.com/hurdles-associated-with-conducting-multinational-clinical-trials-in-developing-countries-such-as-south-africa/ 2021-07-20T20:46:37+00:00 https://old.journalforclinicalstudies.com/42-clinical-trials-in-huntingtons-disease-a-review-of-progress-over-the-last-15-years/ 2021-07-20T20:46:00+00:00 https://old.journalforclinicalstudies.com/potential-of-in-vitro-expanded-nk-cells-as-a-higly-cytotoxic-tool-for-fighting-melanoma/ 2021-07-20T20:45:41+00:00 https://old.journalforclinicalstudies.com/incorporating-patient-reported-outcomes-into-comparative-effectiveness-research/ 2021-07-20T20:45:23+00:00 https://old.journalforclinicalstudies.com/good-cold-chains-in-clinical-trial/ 2021-07-20T20:44:56+00:00 https://old.journalforclinicalstudies.com/designing-mobile-solutions-for-patient-and-protocol/ 2021-07-20T20:44:41+00:00 https://old.journalforclinicalstudies.com/hypertensive-disorders-in-pregnancy/ 2021-07-20T20:44:24+00:00 https://old.journalforclinicalstudies.com/new-sunscreen-approval-why-so-complicated/ 2021-07-20T20:43:41+00:00 https://old.journalforclinicalstudies.com/lex-parsimoniae-applied-to-cns-trial-design/ 2021-07-20T20:43:22+00:00 https://old.journalforclinicalstudies.com/breaking-blind-how-electronic-medical-records-can-interfere-with-preservation-of-blinding-in-clinical-trials-of-procedures/ 2021-07-20T20:43:03+00:00 https://old.journalforclinicalstudies.com/thailand-prepare-for-supply-chain-success/ 2021-07-20T20:42:42+00:00 https://old.journalforclinicalstudies.com/transparent-regulations-for-prescription-medicines-the-australian-way/ 2021-07-20T20:42:25+00:00 https://old.journalforclinicalstudies.com/home-surveillance-in-chronic-disease-evidence-for-use-and-evidence-gaps/ 2021-07-20T20:42:05+00:00 https://old.journalforclinicalstudies.com/go-beyond-south-africa-north-africa-francophonic-countries-being-the-next-generation-clinical-trial-destination-in-africa/ 2021-07-20T20:41:44+00:00 https://old.journalforclinicalstudies.com/clinical-research-in-the-united-arab-emirates/ 2021-07-20T20:41:26+00:00 https://old.journalforclinicalstudies.com/increased-awareness-of-indian-population-of-common-skin-conditions-and-its-impact-on-clinical-research-an-insight/ 2021-07-20T20:41:18+00:00 https://old.journalforclinicalstudies.com/biosimilars-experience-to-date-and-the-potential-to-improve-access-in-the-united-states/ 2021-07-20T20:40:45+00:00 https://old.journalforclinicalstudies.com/drug-accountability-and-destruction-reporting-closing-the-clinical-supply-chain-information-loop/ 2021-07-20T20:40:09+00:00 https://old.journalforclinicalstudies.com/compliance-and-quality-improvement-issues-in-behavioural-healthcare-today/ 2021-07-20T20:39:50+00:00 https://old.journalforclinicalstudies.com/improving-data-quality-for-risk-based-monitoring-and-data-review/ 2021-07-20T20:39:32+00:00 https://old.journalforclinicalstudies.com/clinical-trial-data-analysis-optimising-services-in-a-globally-distributed-model/ 2021-07-20T20:39:14+00:00 https://old.journalforclinicalstudies.com/safe-and-secure-how-digital-technology-is-revolutionizing-patient-privacy/ 2021-07-20T20:38:56+00:00 https://old.journalforclinicalstudies.com/going-mobile-with-clinical-trials/ 2021-07-20T20:38:35+00:00 https://old.journalforclinicalstudies.com/informed-consent-in-acute-coronary-syndrome-trials/ 2021-07-20T20:38:15+00:00 https://old.journalforclinicalstudies.com/mci-clinical-trials-within-the-new-alzheimers-criteria/ 2021-07-20T20:36:46+00:00 https://old.journalforclinicalstudies.com/improving-blood-pressure-management-application-of-arterial-stiffness-and-pressure-wave-reflections/ 2021-07-20T20:36:01+00:00 https://old.journalforclinicalstudies.com/regulatory-requirements-for-registration-of-pharmaceutical-product-in-china/ 2021-07-20T20:35:43+00:00 https://old.journalforclinicalstudies.com/minimisation-of-systematic-deviations-an-example-of-risk-management-in-the-conduct-of-clinical-trials/ 2021-07-20T20:35:30+00:00 https://old.journalforclinicalstudies.com/patient-safety-narratives-in-clinical-studies/ 2021-07-20T20:35:14+00:00 https://old.journalforclinicalstudies.com/a-survey-of-global-resources-for-clinical-trial-awareness-and-education/ 2021-07-20T20:34:49+00:00 https://old.journalforclinicalstudies.com/three-myths-about-clinical-trials-in-russia/ 2021-07-20T20:34:31+00:00 https://old.journalforclinicalstudies.com/advances-in-allergy-testing-component-resolved-diagnostics/ 2021-07-20T20:34:13+00:00 https://old.journalforclinicalstudies.com/biobank-ethics-committee-for-approval-of-biobanks/ 2021-07-20T20:33:55+00:00 https://old.journalforclinicalstudies.com/know-your-audience-clinical-trials-with-paediatric-populations/ 2021-07-20T20:33:45+00:00 https://old.journalforclinicalstudies.com/eletronic-health-records-in-clinical-research/ 2021-07-20T20:33:04+00:00 https://old.journalforclinicalstudies.com/supply-chain-strategies-for-adaptive-clinical-trials/ 2021-07-20T20:32:47+00:00 https://old.journalforclinicalstudies.com/new-pregnancy-labelling-for-risk-communication/ 2021-07-20T20:32:30+00:00 https://old.journalforclinicalstudies.com/heart-failure-what-can-we-learn-from-the-pulse/ 2021-07-20T20:32:12+00:00 https://old.journalforclinicalstudies.com/ash-2014-a-mirror-on-progress-challenges-and-opportunity-for-new-therapies-in-haematologic-malignancies/ 2021-07-20T20:31:54+00:00 https://old.journalforclinicalstudies.com/family-medicine-clinical-trials-enhancement-at-the-patients-level/ 2021-07-20T20:31:11+00:00 https://old.journalforclinicalstudies.com/australia-an-attractive-location-for-clinical-studies/ 2021-07-20T20:30:44+00:00